Heat stress induced cell death mechanisms in hepatocytes and hepatocellular carcinoma: In vitro and in vivo study

Lasers in Surgery and Medicine

Volumn 46, Issue 4, 2014, Pages 290-301

  Thompson, Scott M ^a   Callstrom, Matthew R ^a   Butters, Kim A ^a   Knudsen, Bruce ^a   Grande, Joseph P ^a   Roberts, Lewis R ^a   Woodrum, David A ^a  

^a MAYO CLINIC   (United States)

Author keywords

apoptosis; necroptosis; necrosis

Indexed keywords

CASPASE 3; CASPASE 7; LUCIFERASE; NECROSTATIN 1; PHOSPHOTRANSFERASE; PHOSPHOTRANSFERASE INHIBITOR; RIPK1 KINASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BIOLUMINESCENCE; CANCER SIZE; CELL DEATH; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; ENZYME ACTIVITY; HEAT STRESS; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LASER THERMAL ABLATION; LIVER CELL; LIVER CELL CARCINOMA; NECROPTOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; RAT; TUMOR ABLATION; ADVERSE EFFECTS; ANIMAL; CARCINOMA, HEPATOCELLULAR; EVALUATION STUDY; HEAT; LIVER NEOPLASMS; LOW LEVEL LASER THERAPY; PHYSIOLOGY; RANDOMIZATION; TUMOR CELL LINE;

ANIMALS; APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; HEPATOCYTES; HOT TEMPERATURE; LASER THERAPY; LIVER NEOPLASMS; RANDOM ALLOCATION; RATS;

EID: 84898987819     PISSN: 01968092     EISSN: 10969101     Source Type: Journal    
DOI: 10.1002/lsm.22231     Document Type: Article

References (49)

1. Lencioni R, Crocetti L,. Local-regional treatment of hepatocellular carcinoma. Radiology 2012; 262 (1): 43-58.
2. Francica G, Petrolati A, Di Stasio E, Pacella S, Stasi R, Pacella CM,. Effectiveness, safety, and local progression after percutaneous laser ablation for hepatocellular carcinoma nodules up to 4 cm are not affected by tumor location. AJR Am J Roentgenol 2012; 199 (6): 1393-1401.
3. Arienti V, Pretolani S, Pacella CM, Magnolfi F, Caspani B, Francica G, Megna AS, Regine R, Sponza M, Antico E, Di Lascio FM,. Complications of laser ablation for hepatocellular carcinoma: A multicenter study. Radiology 2008; 246 (3): 947-955.
4. Pacella CM, Francica G, Di Lascio FM, Arienti V, Antico E, Caspani B, Magnolfi F, Megna AS, Pretolani S, Regine R, Sponza M, Stasi R,. Long-term outcome of cirrhotic patients with early hepatocellular carcinoma treated with ultrasound-guided percutaneous laser ablation: A retrospective analysis. J Clin Oncol 2009; 27 (16): 2615-2621.
5. Tiong L, Maddern GJ,. Systematic review and meta-analysis of survival and disease recurrence after radiofrequency ablation for hepatocellular carcinoma. Br J Surg 2011; 98 (9): 1210-1224.
6. Wang JH, Wang CC, Hung CH, Chen CL, Lu SN,. Survival comparison between surgical resection and radiofrequency ablation for patients in BCLC very early/early stage hepatocellular carcinoma. J Hepatol 2012; 56 (2): 412-418.
7. Cho YK, Kim JK, Kim MY, Rhim H, Han JK,. Systematic review of randomized trials for hepatocellular carcinoma treated with percutaneous ablation therapies. Hepatology 2009; 49 (2): 453-459.
8. Yin XY, Xie XY, Lu MD, Xu HX, Xu ZF, Kuang M, Liu GJ, Liang JY, Lau WY,. Percutaneous thermal ablation of medium and large hepatocellular carcinoma: Long-term outcome and prognostic factors. Cancer 2009; 115 (9): 1914-1923.
9. Ng KK, Poon RT, Lo CM, Yuen J, Tso WK, Fan ST,. Analysis of recurrence pattern and its influence on survival outcome after radiofrequency ablation of hepatocellular carcinoma. J Gastrointest Surg 2008; 12 (1): 183-191.
10. Liu Y, Zheng Y, Li S, Li B, Zhang Y, Yuan Y,. Percutaneous microwave ablation of larger hepatocellular carcinoma. Clin Radiol 2013; 68 (1): 21-26.
11. Harrison LE, Koneru B, Baramipour P, Fisher A, Barone A, Wilson D, Dela Torre A, Cho KC, Contractor D, Korogodsky M,. Locoregional recurrences are frequent after radiofrequency ablation for hepatocellular carcinoma. J Am Coll Surg 2003; 197 (5): 759-764.
12. Kei SK, Rhim H, Choi D, Lee WJ, Lim HK, Kim YS,. Local tumor progression after radiofrequency ablation of liver tumors: Analysis of morphologic pattern and site of recurrence. AJR Am J Roentgenol 2008; 190 (6): 1544-1551.
13. Liu CH, Arellano RS, Uppot RN, Samir AE, Gervais DA, Mueller PR,. Radiofrequency ablation of hepatic tumours: Effect of post-ablation margin on local tumour progression. Eur Radiol 2010; 20 (4): 877-885.
14. Stauffer PR, Goldberg SN,. Introduction: Thermal ablation therapy. Int J Hyperthermia 2004; 20 (7): 671-677.
15. Mertyna P, Hines-Peralta A, Liu ZJ, Halpern E, Goldberg W, Goldberg SN,. Radiofrequency ablation: Variability in heat sensitivity in tumors and tissues. J Vasc Interv Radiol 2007; 18 (5): 647-654.
16. Vidair CA, Dewey WC,. Two distinct modes of hyperthermic cell death. Radiat Res 1988; 116 (1): 157-171.
17. McGahan JP, Browning PD, Brock JM, Tesluk H,. Hepatic ablation using radiofrequency electrocautery. Invest Radiol 1990; 25 (3): 267-270.
18. Goldberg SN, Gazelle GS, Halpern EF, Rittman WJ, Mueller PR, Rosenthal DI,. Radiofrequency tissue ablation: Importance of local temperature along the electrode tip exposure in determining lesion shape and size. Acad Radiol 1996; 3 (3): 212-218.
19. Ouyang L, Shi Z, Zhao S, Wang FT, Zhou TT, Liu B, Bao JK,. Programmed cell death pathways in cancer: A review of apoptosis, autophagy and programmed necrosis. Cell Prolif 2012; 45 (6): 487-498.
20. Mertyna P, Dewhirst MW, Halpern E, Goldberg W, Goldberg SN,. Radiofrequency ablation: The effect of distance and baseline temperature on thermal dose required for coagulation. Int J Hyperthermia 2008; 24 (7): 550-559.
21. Reed JC,. Drug insight: Cancer therapy strategies based on restoration of endogenous cell death mechanisms. Nat Clin Pract Oncol 2006; 3 (7): 388-398.
22. Thompson SM, Callstrom MR, Butters KA, Sutor SL, Knudsen B, Grande JP, Roberts LR, Woodrum DA,. Role for putative hepatocellular carcinoma stem cell subpopulations in biological response to incomplete thermal ablation: In vitro and in vivo pilot study. Cardiovasc Intervent Radiol 2014; Epub ahead of print.
23. Niles AL, Moravec RA, Eric Hesselberth P, Scurria MA, Daily WJ, Riss TL,. A homogeneous assay to measure live and dead cells in the same sample by detecting different protease markers. Anal Biochem 2007; 366 (2): 197-206.
24. Niles AL, Moravec RA, Riss TL,. In vitro viability and cytotoxicity testing and same-well multi-parametric combinations for high throughput screening. Curr Chem Genomics 2009; 3: 33-41.
25. Degterev A, Hitomi J, Germscheid M, Ch'en IL, Korkina O, Teng X, Abbott D, Cuny GD, Yuan C, Wagner G, Hedrick SM, Gerber SA, Lugovskoy A, Yuan J,. Identification of RIP1 kinase as a specific cellular target of necrostatins. Nat Chem Biol 2008; 4 (5): 313-321.
26. Thompson SM, Callstrom MR, Knudsen BE, Anderson JL, Sutor SL, Butters KA, Kuo C, Grande JP, Roberts LR, Woodrum DA,. Molecular bioluminescence imaging as a noninvasive tool for monitoring tumor growth and therapeutic response to MRI-guided laser ablation in a rat model of hepatocellular carcinoma. Invest Radiol 2013; 48 (6): 413-421.
27. Thompson SM, Callstrom MR, Knudsen B, Anderson JL, Carter RE, Grande JP, Roberts LR, Woodrum DA,. Development and preliminary testing of a translational model of hepatocellular carcinoma for MR imaging and interventional oncologic investigations. J Vasc Interv Radiol 2012; 23 (3): 385-395.
28. Hickson J, Ackler S, Klaubert D, Bouska J, Ellis P, Foster K, Oleksijew A, Rodriguez L, Schlessinger S, Wang B, Frost D,. Noninvasive molecular imaging of apoptosis in vivo using a modified firefly luciferase substrate, Z-DEVD-aminoluciferin. Cell Death Differ 2010; 17 (6): 1003-1010.
29. Scabini M, Stellari F, Cappella P, Rizzitano S, Texido G, Pesenti E,. In vivo imaging of early stage apoptosis by measuring real-time caspase-3/7 activation. Apoptosis 2011; 16 (2): 198-207.
30. Thompson SM, Callstrom MR, Knudsen B, Anderson JL, Butters KA, Grande JP, Roberts LR, Woodrum DA,. AS30D model of hepatocellular carcinoma: Tumorigenicity and preliminary characterization by imaging, histopathology, and immunohistochemistry. Cardiovasc Intervent Radiol 2013; 36 (1): 198-203.
31. Vandenabeele P, Galluzzi L, Vanden Berghe T, Kroemer G,. Molecular mechanisms of necroptosis: An ordered cellular explosion. Nat Rev Mol Cell Biol 2010; 11 (10): 700-714.
32. Degterev A, Huang Z, Boyce M, Li Y, Jagtap P, Mizushima N, Cuny GD, Mitchison TJ, Moskowitz MA, Yuan J,. Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat Chem Biol 2005; 1 (2): 112-119.
33. Galluzzi L, Maiuri MC, Vitale I, Zischka H, Castedo M, Zitvogel L, Kroemer G,. Cell death modalities: Classification and pathophysiological implications. Cell Death Differ 2007; 14 (7): 1237-1243.
34. Kroemer G, Galluzzi L, Vandenabeele P, Abrams J, Alnemri ES, Baehrecke EH, Blagosklonny MV, El-Deiry WS, Golstein P, Green DR, Hengartner M, Knight RA, Kumar S, Lipton SA, Malorni W, Nunez G, Peter ME, Tschopp J, Yuan J, Piacentini M, Zhivotovsky B, Melino G,. Classification of cell death: Recommendations of the Nomenclature Committee on Cell Death 2009. Cell Death Differ 2009; 16 (1): 3-11.
35. Malhi H, Gores GJ, Lemasters JJ,. Apoptosis and necrosis in the liver: A tale of two deaths ? Hepatology 2006; 43 (2 Suppl 1): S31-S44.
36. Galluzzi L, Vitale I, Abrams JM, Alnemri ES, Baehrecke EH, Blagosklonny MV, Dawson TM, Dawson VL, El-Deiry WS, Fulda S, Gottlieb E, Green DR, Hengartner MO, Kepp O, Knight RA, Kumar S, Lipton SA, Lu X, Madeo F, Malorni W, Mehlen P, Nunez G, Peter ME, Piacentini M, Rubinsztein DC, Shi Y, Simon HU, Vandenabeele P, White E, Yuan J, Zhivotovsky B, Melino G, Kroemer G,. Molecular definitions of cell death subroutines: Recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death Differ 2012; 19 (1): 107-120.
37. Long JS, Ryan KM,. New frontiers in promoting tumour cell death: Targeting apoptosis, necroptosis and autophagy. Oncogene 2012; 31 (49): 5045-5060.
38. Hoshida Y, Toffanin S, Lachenmayer A, Villanueva A, Minguez B, Llovet JM,. Molecular classification and novel targets in hepatocellular carcinoma: Recent advancements. Semin Liver Dis 2010; 30 (1): 35-51.
39. Lee JS, Heo J, Libbrecht L, Chu IS, Kaposi-Novak P, Calvisi DF, Mikaelyan A, Roberts LR, Demetris AJ, Sun Z, Nevens F, Roskams T, Thorgeirsson SS,. A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells. Nat Med 2006; 12 (4): 410-416.
40. Harmon BV, Corder AM, Collins RJ, Gobe GC, Allen J, Allan DJ, Kerr JF,. Cell death induced in a murine mastocytoma by 42-47°C heating in vitro: Evidence that the form of death changes from apoptosis to necrosis above a critical heat load. Int J Radiat Biol 1990; 58 (5): 845-858.
41. VanderWaal R, Malyapa RS, Higashikubo R, Roti Roti JL,. A comparison of the modes and kinetics of heat-induced cell killing in HeLa and L5178Y cells. Radiat Res 1997; 148 (5): 455-462.
42. Vanagas T, Gulbinas A, Sadauskiene I, Dambrauskas Z, Pundzius J, Barauskas G,. Apoptosis is activated in an early period after radiofrequency ablation of liver tissue. Hepatogastroenterology 2009; 56 (93): 1095-1099.
43. Yang W, Ahmed M, Elian M, Hady el SA, Levchenko TS, Sawant RR, Signoretti S, Collins M, Torchilin VP, Goldberg SN,. Do liposomal apoptotic enhancers increase tumor coagulation and end-point survival in percutaneous radiofrequency ablation of tumors in a rat tumor model ? Radiology 2010; 257 (3): 685-696.
44. Solazzo SA, Ahmed M, Schor-Bardach R, Yang W, Girnun GD, Rahmanuddin S, Levchenko T, Signoretti S, Spitz DR, Torchilin V, Goldberg SN,. Liposomal doxorubicin increases radiofrequency ablation-induced tumor destruction by increasing cellular oxidative and nitrative stress and accelerating apoptotic pathways. Radiology 2010; 255 (1): 62-74.
45. Hanahan D, Weinberg RA,. Hallmarks of cancer: The next generation. Cell 2011; 144 (5): 646-674.
46. Fabregat I,. Dysregulation of apoptosis in hepatocellular carcinoma cells. World J Gastroenterol 2009; 15 (5): 513-520.
47. Fabregat I, Roncero C, Fernandez M,. Survival and apoptosis: A dysregulated balance in liver cancer. Liver Int 2007; 27 (2): 155-162.
48. Schattenberg JM, Schuchmann M, Galle PR,. Cell death and hepatocarcinogenesis: Dysregulation of apoptosis signaling pathways. J Gastroenterol Hepatol 2011; 26 (Suppl 1): 213-219.
49. Kepp O, Galluzzi L, Lipinski M, Yuan J, Kroemer G,. Cell death assays for drug discovery. Nat Rev Drug Discov 2011; 10 (3): 221-237.